Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
The British Journal of Diabetes & Vascular Disease
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Leese, G. P
Right arrow Articles by Ellis, J. D
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Reviews

Review: Overview of diabetic eye disease

Graham P Leese

Ninewells Hospital and Medical School, Dundee, DD1 9SY, UK, graham.leese{at}tuht.scot.nhs.uk

John D Ellis

Visual impairment in diabetes is much more common than blindness, and causes major functional disability. Much of this could be avoided by early detection using comprehensive eye screening programmes. These would be most efficiently delivered by digital photography, and automated grading of normal images. Slit lamp examination would provide back-up for patients whose eyes are difficult to examine. It may be possible to extend screening intervals for patients with no baseline retinopathy. There is strong evidence that aggressive glycaemic and blood pressure control prevent development and progression of retinal disease. Laser treatment is less successful in preventing visual loss in maculopathy than in proliferative retinopathy. New drugs such as protein kinase-C inhibitors may become available to treat diabetic retinal disease.

Key Words: diabetes • retinopathy • maculopathy • visual impairment.

References

  • Brown MM, Brown GC, Sharma S., Shah G. Utility values and diabetic retinopathy. Am J Ophthalmol 1999;128:324-30.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Mulhauser I., Bender R., Bott U. et al. Cigarette smoking and progression of retinopathy and nephropathy in type 1 diabetes. Diabetic Med 1996;13:536-43.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Karamanos B., Porta M., Songini M. et al. Different risk factors of macroangiopathy in patients with type-1 diabetes mellitus of short versus long duration. The EURODIAB IDDM complications study. Diabetologia 2000;43:348-55.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Stratton IM, Kohner EM, Aldington SJ et al. Risk factors for incidence and progression of retinopathy in type II diabetes over 6 years from diagnosis (UKPDS 50). Diabetologia 2001;44:156-63.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Klein BE, Moss SE, Klein R. Effect of pregnancy on progression of diabetic retinopathy. Diabetes Care 1990;13:34-40.[Abstract]
  • Rosenn B., Miodovnik M., Kranias G. et al. Progression of diabetic retinopathy in pregnancy: association with hypertension in pregnancy. Am J Obstet Gynaecol 1992;166:1214-8.[Web of Science][Medline] [Order article via Infotrieve]
  • Klein R., Meuer SM, Moss SE, Klein BE Retinal microaneurysm counts and 10-year progression of diabetic retinopathy. Arch Ophthalmol 1995; 113:1386-91.[Abstract/Free Full Text]
  • Diabetes Control and Complications Trial. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.[Abstract/Free Full Text]
  • UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risks of complications in patients with type-2 diabetes (UKPDS 33). Lancet 1998;352:837-53.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Diabetes Control and Complications Trial. Early worsening of diabetic retinopathy in the diabetes control and complications trial. Arch Ophthalmol 1998;116:874-86.[Abstract/Free Full Text]
  • Dowler JG, Hykin PG, Lightman SL, Hamilton AM Visual acuity following extracapsular cataract extraction in diabetes: a meta analysis. Eye 1995;9:313-7.[Web of Science][Medline] [Order article via Infotrieve]
  • Klein R., Klein BEK, Moss SE et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy II - prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1984;102:520-6.[Abstract/Free Full Text]
  • Klein R., Klein BEK, Moss SE et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy III - prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 1984;102(4):527-32.[Abstract/Free Full Text]
  • Javitt JC, Canner JK, Sommer A. Cost effectiveness of current approaches to the control of retinopathy in type I diabetics. Ophthalmol 1989;96:255-64.
  • Trautner C., Icks A., Haastert B., Plum F., Berger M. Incidence of blindness in relation to diabetes. A population-based study. Diabetes Care 1997;20(7):1147-53.[Abstract]
  • Rhatigan MC, Leese GP, Ellis J. et al. Blindness in patients with diabetes who have been screened for eye disease. Eye 1999;13:166-9.[Web of Science][Medline] [Order article via Infotrieve]
  • Kohner EM, Stratton IM, Aldington SJ, Holman RR, Matthews DR Relationship between the severity of retinopathy and progression to photocoagulation in patients with type-2 diabetes in the UKPDS (UKPDS 52). Diabetic Med 2001;18:178-84.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Hutchinson A., McIntosh A., Peters J. et al. Effectiveness of screening and monitoring tests for diabetic retinopathy - a systematic review. Diabetic Med 2000;17:495-506.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Taylor R. Practical community screening for diabetic retinopathy using the mobile retinal camera: Report of a 12 centre study. Diabetic Med 1996; 13:946-52.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Gatling W., Howie AJ, Hill RD An optical practice based diabetic eye screening programme. Diabetic Med 1995;12:531-6.[Web of Science][Medline] [Order article via Infotrieve]
  • Leese GP, Tesfaye S., Dengler-Harles M. et al. Screening for diabetic eye disease by optometrists using slit lamps. J Roy Coll Physicians Lon 1997;31:65-9.
  • Klein R., Klein BE, Neider MW et al. Diabetic retinopathy as detected using ophthalmoscopy, a nonmydriatic camera and a standard fundus camera. Ophthalmol 1985;92:485-91.
  • Lairson DR, Pugh JA, Kapadia AS et al. Cost-effectiveness of alternative methods for diabetic retinopathy screening. Diabetes Care 1992;15:1369-77.[Abstract]
  • Health Technology Board for Scotland. Organisation of services for diabetic retinopathy screening - draft report. Health Technology Board Scotland, NHS Scotland 2001.
  • Ryder RE, Kong N., Bates AS, Sim J., Welch J., Kritzinger EE Instant electronic imaging systems are superior to Polaroid at detecting sight-threatening retinopathy. Diabetic Med 1998;15:254-8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Hipwell JH, Strachan F., Olson JA, McHardy KC, Sharp PF, Forrester JV Automated detection of microaneurysms in digital red-free photographs: a diabetic retinopathy screening tool. Diabetic Med 2000;17:588-94.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Javitt JC, Aiello LP Cost effectiveness of detecting and treating diabetic retinopathy. Ann Intern Med 1996;124:164-9.[Abstract/Free Full Text]
  • Diabetic Retinopathy Study Research Group. DRS group 8: photocoagulation treatment of proliferative diabetic retinopathy. Ophthalmol 1981; 88:583-600.
  • Early treatment of diabetic retinopathy study. Photocoagulation for diabetic macula oedema: report IV. Int Ophthalmol Clin 1987;27:265-72.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Ferris FL How effective are treatments for diabetic retinopathy? JAMA 1993;269:1290-1.[Abstract/Free Full Text]
  • Early vitrectomy for severe vitreous haemorrhage in diabetic retinopathy. Two year results of a randomized trial: Diabetic retinopathy vitrectomy study report 2. Arch Ophthalmol 1985;103:1644-52.[Abstract/Free Full Text]
  • Chaturvedi N., Sjolie AK, Stephenson JM et al. Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. Lancet 1998;351:28-31.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • UK Prospective Diabetes Study Group. UKPDS 38. Tight blood pressure control and risk of macrovascular and microvascular complications in type-2 diabetes. BMJ 1998;317:703-13.[Abstract/Free Full Text]
  • Danis RP, Bingaman DP, Jirousek M., Yang Y. Inhibition of intraocular neo-vascularisation caused by retinal ischaemia in pigs by PKC- inhibition with LY333531. Invest Ophthalmol Vis Sci 1998;39:171-9.[Abstract/Free Full Text]
  • Bailey CC, Sparrow JM, Grey RHB, Cheng H. The national diabetic retinopathy laser treatment audit. II Proliferative retinopathy. Eye 1998; 12:77-84.[Web of Science][Medline] [Order article via Infotrieve]
  • UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: (UKPDS 38). BMJ 1998;317:703-13.[Abstract/Free Full Text]
  • Savage E., Estacio RO, Jeffers B., Schrier RW Urinary albumin excretion as a predictor of diabeteic retinopathy and cardiovascular disease in NIDDM. Diabetes Care 1996;19:1243-8.[Abstract]
  • Davies MD, Fisher MR, Gangnon RE, Barton F., Aiello LM, Chew EY Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report No 18. Invest Ophthalmol Vis Sci 1998;39:233-52.[Abstract/Free Full Text]

The British Journal of Diabetes & Vascular Disease, Vol. 2, No. 1, 14-17 (2002)
DOI: 10.1177/14746514020020011201
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Leese, G. P
Right arrow Articles by Ellis, J. D
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?